Withdrawn trial aimed to stop bladder Cancer's return
NCT ID NCT07313891
Summary
This study planned to test whether a new drug called NDV-01 could help prevent cancer from coming back in people with intermediate-risk, non-muscle invasive bladder cancer. Participants would have had their tumors removed and then been randomly assigned to either receive the drug directly into the bladder for up to a year or just be monitored with regular check-ups. The goal was to see if the drug treatment led to a longer period without the cancer returning compared to observation alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.